300181 佐力药业
已收盘 05-17 15:00:00
资讯
新帖
简况
佐力药业最新公告:2023年度权益分派10派4.5元 股权登记日5月21日
证券之星 · 05-15
佐力药业最新公告:2023年度权益分派10派4.5元 股权登记日5月21日
佐力药业(300181.SZ)2023年度拟每10股派4.5元 5月22日除权除息
智通财经 · 05-15
佐力药业(300181.SZ)2023年度拟每10股派4.5元 5月22日除权除息
佐力药业(300181)5月15日主力资金净卖出1.02亿元
证券之星 · 05-15
佐力药业(300181)5月15日主力资金净卖出1.02亿元
佐力药业最新公告:灵香片获得药物临床试验批准通知书
证券之星 · 05-14
佐力药业最新公告:灵香片获得药物临床试验批准通知书
佐力药业(300181.SZ):灵香片获药物临床试验批准
智通财经 · 05-14
佐力药业(300181.SZ):灵香片获药物临床试验批准
佐力药业(300181)5月9日主力资金净卖出1467.51万元
证券之星 · 05-09
佐力药业(300181)5月9日主力资金净卖出1467.51万元
佐力药业:副总经理马爱华因未依法履行其他职责被证监会约见谈话
证券之星 · 05-01
佐力药业:副总经理马爱华因未依法履行其他职责被证监会约见谈话
佐力药业:公司控股子公司涉诉案件已进行第一次开庭审理;公司百令片的生产销售情况一切正常
证券之星 · 04-25
佐力药业:公司控股子公司涉诉案件已进行第一次开庭审理;公司百令片的生产销售情况一切正常
西南证券:给予佐力药业买入评级
证券之星 · 04-23
西南证券:给予佐力药业买入评级
佐力药业(300181)4月23日主力资金净卖出7304.10万元
证券之星 · 04-23
佐力药业(300181)4月23日主力资金净卖出7304.10万元
佐力药业(300181.SZ):灵莲花颗粒转换为非处方药获批
智通财经网 · 04-02
佐力药业(300181.SZ):灵莲花颗粒转换为非处方药获批
新一轮“涨价潮”袭来!中药板块全面爆发,机构:看好四大方向
格隆汇 · 03-12
新一轮“涨价潮”袭来!中药板块全面爆发,机构:看好四大方向
佐力药业(300181.SZ)发预增,预计一季度净利润1.37亿元至1.47亿元,同比增长40.58%至50.84%
智通财经网 · 03-11
佐力药业(300181.SZ)发预增,预计一季度净利润1.37亿元至1.47亿元,同比增长40.58%至50.84%
华东医药创新转型扣非超27亿元达新高 大单品百令胶囊遭遇佐力药业“争夺战”
市场资讯 · 02-03
华东医药创新转型扣非超27亿元达新高 大单品百令胶囊遭遇佐力药业“争夺战”
佐力药业(300181.SZ)发预增,预计2023年度净利润3.8亿元-4亿元,同比增长39.19%-46.52%
智通财经网 · 01-25
佐力药业(300181.SZ)发预增,预计2023年度净利润3.8亿元-4亿元,同比增长39.19%-46.52%
佐力药业(300181.SZ):百令胶囊获药品注册证书
智通财经网 · 01-07
佐力药业(300181.SZ):百令胶囊获药品注册证书
佐力药业(300181.SZ):乌灵胶囊拟中选福建省第四批药品集中带量采购
智通财经网 · 2023-12-25
佐力药业(300181.SZ):乌灵胶囊拟中选福建省第四批药品集中带量采购
加载更多
公司概况
公司名称:
浙江佐力药业股份有限公司
所属行业:
医药制造业
上市日期:
2011-02-22
主营业务:
浙江佐力药业股份有限公司主营业务为药品的研发、生产和销售。公司主要产品包括乌灵系列(乌灵胶囊、灵泽片、灵莲花颗粒)、百令系列(百令片、百令胶囊)、中药饮片及中药配方颗粒、聚卡波非钙片等。公司荣获“全国文明单位”、“国家级绿色工厂”、“浙江省知名商号”、“浙江省信用管理示范企业”、“浙江省中医药文化宣传教育基地”、“2022-2023年度中华民族医药优秀品牌企业”、“2022-2023年度中国医药行业成长50强”、“2023年中成药综合竞争力50强”、“2023年度最具社会责任(ESG)上市公司”企业等称号和荣誉。
发行价格:
23.50
{"stockData":{"symbol":"300181","market":"SZ","secType":"STK","nameCN":"佐力药业","latestPrice":15.67,"timestamp":1715929422000,"preClose":15.71,"halted":0,"volume":17964306,"delay":0,"floatShares":601000000,"shares":701000000,"eps":0.6101,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.04,"latestTime":"05-17 15:00:00","open":15.71,"high":15.85,"low":15.46,"amount":281000000,"amplitude":0.0248,"askPrice":15.68,"askSize":108,"bidPrice":15.67,"bidSize":52,"shortable":0,"etf":0,"ttmEps":0.6101,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":15.71,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":17.28,"lowLimit":14.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":701387335,"pbRate":3.85,"roa":"--","roe":"5.09%","epsLYR":0.55,"committee":0.268487,"marketValue":10991000000,"floatMarketCap":9421000000,"peRate":25.684315,"changeRate":-0.0025,"turnoverRate":0.0299,"status":1},"requestUrl":"/m/hq/s/300181/","defaultTab":"news","newsList":[{"id":"2435639014","title":"佐力药业最新公告:2023年度权益分派10派4.5元 股权登记日5月21日","url":"https://stock-news.laohu8.com/highlight/detail?id=2435639014","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435639014?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:49","pubTimestamp":1715773792,"startTime":"0","endTime":"0","summary":"佐力药业公告,公司2023年年度权益分派方案为:向全体股东每10股派4.5元人民币现金(含税)。本次权益分派股权登记日为:2024年5月21日;除权除息日为:2024年5月22日。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500033816.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435635875","title":"佐力药业(300181.SZ)2023年度拟每10股派4.5元 5月22日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2435635875","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435635875?lang=zh_cn&edition=full","pubTime":"2024-05-15 19:02","pubTimestamp":1715770937,"startTime":"0","endTime":"0","summary":"智通财经APP讯,佐力药业(300181.SZ)公告,公司2023年年度拟向全体股东每10股派发现金股利人民币4.5元(含税),本次权益分派股权登记日为2024年5月21日,除权除息日为2024年5月22日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1121610.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2435688444","title":"佐力药业(300181)5月15日主力资金净卖出1.02亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435688444","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435688444?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:26","pubTimestamp":1715757975,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月15日收盘,佐力药业报收于15.99元,下跌4.88%,换手率6.1%,成交量36.66万手,成交额6.02亿元。5月15日的资金流向数据方面,主力资金净流出1.02亿元,占总成交额16.88%,游资资金净流入3495.23万元,占总成交额5.81%,散户资金净流入6667.53万元,占总成交额11.08%。佐力药业主营业务:药品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500022422.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435985865","title":"佐力药业最新公告:灵香片获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2435985865","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435985865?lang=zh_cn&edition=full","pubTime":"2024-05-14 17:41","pubTimestamp":1715679680,"startTime":"0","endTime":"0","summary":"佐力药业公告,灵香片获得药物临床试验批准通知书。灵香片作为公司乌灵系列的新产品,属于妇科类,是以乌灵菌粉入药,按现代中医理论指导组方治疗现代疾病的中药制剂。目前国内尚无适应症为治疗盆腔炎性疾病后遗症慢性盆腔痛的中成药品种获批上市。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400026813.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435600605","title":"佐力药业(300181.SZ):灵香片获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2435600605","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2435600605?lang=zh_cn&edition=full","pubTime":"2024-05-14 17:41","pubTimestamp":1715679666,"startTime":"0","endTime":"0","summary":"智通财经APP讯,佐力药业(300181.SZ)公告,公司近日收到国家药品监督管理局签发的《药物临床试验批准通知书》,公司自主研发的灵香片将开展临床试验研究(用于盆腔炎性疾病后遗症慢性盆腔痛)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1121144.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434052218","title":"佐力药业(300181)5月9日主力资金净卖出1467.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434052218","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434052218?lang=zh_cn&edition=full","pubTime":"2024-05-09 15:26","pubTimestamp":1715239617,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年5月9日收盘,佐力药业报收于15.63元,下跌0.89%,换手率2.66%,成交量16.01万手,成交额2.51亿元。5月9日的资金流向数据方面,主力资金净流出1467.51万元,占总成交额5.85%,游资资金净流出652.5万元,占总成交额2.6%,散户资金净流入2120.01万元,占总成交额8.46%。佐力药业主营业务:药品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900022170.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432305609","title":"佐力药业:副总经理马爱华因未依法履行其他职责被证监会约见谈话","url":"https://stock-news.laohu8.com/highlight/detail?id=2432305609","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2432305609?lang=zh_cn&edition=full","pubTime":"2024-05-01 01:01","pubTimestamp":1714496462,"startTime":"0","endTime":"0","summary":"证券之星消息,4月30日佐力药业公开信息显示,副总经理马爱华因未依法履行其他职责被中国证券监督管理委员会浙江监管局约见谈话。详细违规行为如下:你作为浙江佐力药业股份有限公司副总经理,你配偶陆秀梅证券账户于2023年10月23日至10月26日期间累计买入公司股票23,000股,成交金额220,040元;并于2024年4月19日至4月22日期间累计卖出公司股票51,400股,成交金额763,900元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050100002131.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430862404","title":"佐力药业:公司控股子公司涉诉案件已进行第一次开庭审理;公司百令片的生产销售情况一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2430862404","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430862404?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:01","pubTimestamp":1714046491,"startTime":"0","endTime":"0","summary":"乌灵菌粉目前的产能相对来说比较饱满,公司建设中的募投项目药用真菌发酵数字化车间扩产完成后,乌灵菌粉的年产量将从600吨增加到900吨。涉讼产品现在是否已经开始生产及销售?公司控股子公司涉诉案件已进行第一次开庭审理;公司百令片的生产销售情况一切正常。乌灵菌粉是国家中药一类新药,公司以乌灵菌粉为原料开发独家乌灵系列创新药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500042206.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429165392","title":"西南证券:给予佐力药业买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429165392","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429165392?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:50","pubTimestamp":1713862248,"startTime":"0","endTime":"0","summary":"西南证券股份有限公司杜向阳近期对佐力药业进行研究并发布了研究报告《2024Q1业绩超预期,乌灵胶囊增速亮眼》,本报告对佐力药业给出买入评级,当前股价为14.52元。 佐力药业 事件:公司发布2023年年报及2024年一季报。预计2024-2026年归母净利润分别为5.2亿元、6.3亿元、7.7亿元,对应同比增速分别为37%/21%/21%,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有8家机构给出评级,买入评级7家,增持评级1家;过去90天内机构目标均价为18.25。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031298.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429154998","title":"佐力药业(300181)4月23日主力资金净卖出7304.10万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429154998","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429154998?lang=zh_cn&edition=full","pubTime":"2024-04-23 15:30","pubTimestamp":1713857425,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年4月23日收盘,佐力药业报收于14.52元,下跌3.01%,换手率4.92%,成交量29.59万手,成交额4.31亿元。4月23日的资金流向数据方面,主力资金净流出7304.1万元,占总成交额16.95%,游资资金净流出425.42万元,占总成交额0.99%,散户资金净流入7729.52万元,占总成交额17.93%。佐力药业主营业务:药品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300023705.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424015459","title":"佐力药业(300181.SZ):灵莲花颗粒转换为非处方药获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2424015459","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2424015459?lang=zh_cn&edition=full","pubTime":"2024-04-02 19:26","pubTimestamp":1712057160,"startTime":"0","endTime":"0","summary":"佐力药业(300181.SZ)公告,公司于近日获悉,经国家药品监督管理局组织论证和审核,公司独家品种灵莲花颗粒由处方药转换为非处方药;其功能主治:养阴安神,交通心肾。用于围绝经期综合征属心肾不交者,症见烘热汗出、失眠、心烦不宁、心悸、多梦易惊、头晕耳鸣、腰膝酸痛、大便干燥、舌红苔薄、脉细弦。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-02/doc-inaqmynn4871158.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-02/doc-inaqmynn4871158.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2418321382","title":"新一轮“涨价潮”袭来!中药板块全面爆发,机构:看好四大方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2418321382","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2418321382?lang=zh_cn&edition=full","pubTime":"2024-03-12 10:54","pubTimestamp":1710212050,"startTime":"0","endTime":"0","summary":"风口真的来了","market":"sg","thumbnail":"https://img3.gelonghui.com/8fff8-0965ea83-bcfc-40c7-84fd-72a109d7c00f.jpg?guru_height=853&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/8fff8-0965ea83-bcfc-40c7-84fd-72a109d7c00f.jpg?guru_height=853&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/705367","is_publish_highlight":false,"gpt_icon":0},{"id":"2418331172","title":"佐力药业(300181.SZ)发预增,预计一季度净利润1.37亿元至1.47亿元,同比增长40.58%至50.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418331172","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2418331172?lang=zh_cn&edition=full","pubTime":"2024-03-11 18:04","pubTimestamp":1710151440,"startTime":"0","endTime":"0","summary":"佐力药业(300181.SZ)披露2024年第一季度业绩预告,公司预计归属于上市公司股东的净利润1.37亿元至1.47亿元,同比增长40.58%至50.84%;扣除非经常性损益后的净利润1.39亿元至1.5亿元,同比增长45.17%至56.66%。报告期内,公司基于乌灵胶囊、百令片、灵泽片三个核心产品是国家基本药物目录产品的优势,持续加强市场拓展,均取得了增长,其中乌灵胶囊、灵泽片的销售延续了较好的市场增长;中药配方颗粒随着备案品种增加,同比销售增长显著。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-11/doc-inamxxsf8728570.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-11/doc-inamxxsf8728570.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2408032903","title":"华东医药创新转型扣非超27亿元达新高 大单品百令胶囊遭遇佐力药业“争夺战”","url":"https://stock-news.laohu8.com/highlight/detail?id=2408032903","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2408032903?lang=zh_cn&edition=full","pubTime":"2024-02-03 07:48","pubTimestamp":1706917680,"startTime":"0","endTime":"0","summary":" 从扣非净利润的数据来看,华东医药业绩达到上市以来高点。 对此公司表示,去年,华东医药推进创新转型战略,四大业务板块均实现正向增长。 除了来自医保集采降价的影响,华东医药大单品百令胶囊未来收入的挑战或来自佐力药业。此前,华东医药曾将佐力药业告上法庭,被市场质疑阻碍竞品上市。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-02-03/doc-inaftiin5787998.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-02-03/doc-inaftiin5787998.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2406249290","title":"佐力药业(300181.SZ)发预增,预计2023年度净利润3.8亿元-4亿元,同比增长39.19%-46.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406249290","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2406249290?lang=zh_cn&edition=full","pubTime":"2024-01-25 21:05","pubTimestamp":1706187900,"startTime":"0","endTime":"0","summary":"佐力药业(300181.SZ)发布2023年度业绩预告,公司预计2023年度归属于上市公司股东的净利润3.8亿元-4亿元,同比增长39.19%-46.52%;扣除非经常性损益后的净利润3.66亿元-3.86亿元,同比增长38.38%-45.93%。报告期内,公司基于乌灵胶囊、百令片、灵泽片三个核心产品是国家基本药物目录产品的优势,持续加强市场拓展,营业收入较上年同比增长了7.61%。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-25/doc-inaetytz8422261.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-25/doc-inaetytz8422261.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2401664210","title":"佐力药业(300181.SZ):百令胶囊获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2401664210","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2401664210?lang=zh_cn&edition=full","pubTime":"2024-01-07 16:26","pubTimestamp":1704615960,"startTime":"0","endTime":"0","summary":"佐力药业(300181.SZ)发布公告,近日,公司收到国家药品监督管理局签发的百令胶囊《药品注册证书》,百令胶囊功能主治:补肺肾、益精气。用于肺肾两虚引起的咳嗽、气喘、咯血、腰背酸痛、面目虚浮、夜尿清长;慢性支气管炎、慢性肾功能不全的辅助治疗。百令胶囊的获批进一步丰富了公司的产品梯队,有助于提升公司的市场竞争力,为公司发展带来积极影响。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-07/doc-inaasyiz9672564.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-07/doc-inaasyiz9672564.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2394251745","title":"佐力药业(300181.SZ):乌灵胶囊拟中选福建省第四批药品集中带量采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2394251745","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2394251745?lang=zh_cn&edition=full","pubTime":"2023-12-25 16:53","pubTimestamp":1703494380,"startTime":"0","endTime":"0","summary":"佐力药业发布公告,近日,公司参与了福建省第四批药品集中带量采购工作,根据福建省医疗保障局于2023年12月19日发布的《福建省第四批药品集中带量采购公告》显示,公司产品乌灵胶囊拟中选本次集中带量采购,拟中选价46.27元。本次拟中选产品乌灵胶囊为国家基药目录产品,乌灵胶囊于2022年度在福建省的销售量占全国销量的1.64%。乌灵胶囊拟中选本次福建省第四批药品集中带量采购,进一步增加了乌灵胶囊在福建省的竞争能力。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-25/doc-imzzfpwv2962549.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-25/doc-imzzfpwv2962549.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-02-22","address":"浙江省湖州市德清县阜溪街道志远北路388号","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.1607},{"period":"3month","weight":0.5423},{"period":"6month","weight":0.4952},{"period":"1year","weight":0.3303},{"period":"ytd","weight":0.47}],"companyName":"浙江佐力药业股份有限公司","boardCode":"AI0027","perCapita":"16290股","boardName":"医药制造业","registeredCapital":"70138万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":" 浙江佐力药业股份有限公司主营业务为药品的研发、生产和销售。公司主要产品包括乌灵系列(乌灵胶囊、灵泽片、灵莲花颗粒)、百令系列(百令片、百令胶囊)、中药饮片及中药配方颗粒、聚卡波非钙片等。公司荣获“全国文明单位”、“国家级绿色工厂”、“浙江省知名商号”、“浙江省信用管理示范企业”、“浙江省中医药文化宣传教育基地”、“2022-2023年度中华民族医药优秀品牌企业”、“2022-2023年度中国医药行业成长50强”、“2023年中成药综合竞争力50强”、“2023年度最具社会责任(ESG)上市公司”企业等称号和荣誉。","serverTime":1716131419079,"listedPrice":23.5,"stockholders":"36904人(较上一季度减少2.23%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"佐力药业(300181)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供佐力药业(300181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"佐力药业,300181,佐力药业股票,佐力药业股票老虎,佐力药业股票老虎国际,佐力药业行情,佐力药业股票行情,佐力药业股价,佐力药业股市,佐力药业股票价格,佐力药业股票交易,佐力药业股票购买,佐力药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"佐力药业(300181)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供佐力药业(300181)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}